Powering the genetic medicine revolution
Our novel, synthetic DNA vector, “doggybone” or dbDNA™, and its enzymatic production, enable us to make DNA at the speed, scale and purity necessary to support the rapid growth of genetic medicines.
Enzymatic manufacturing enables multi-gram GMP DNA production in weeks rather than months
Manufactured using benchtop equipment with a significantly smaller footprint than fermentation-based production
dbDNA™ technology is highly portable and amenable to technology transfer
dbDNA™ can encode long, complex, unstable sequences, eliminates bacterial sequences, and has a strong expression profile
Addressing a broad market
Our versatile dbDNA™ technology is being applied across the genetic medicine industry.
What can we do for you?
We offer a range of services to support development and commercialisation of the next generation of DNA products.
- Catalogue products
- Molecular biology
- Custom research grade
- Toxicology materials
- GMP dbDNA™ (critical starting materials)
- GMP dbDNA™ (drug substance)
- Commercial supply / on-site supply
- Analytical development
- Scale up development
- Regulatory support
Headquartered in Hampton
Take a tour of our stunning buildings and state-of-the-art dbDNA™ manufacturing facilities.View our facilities
Drug Delivery Today – dbDNA™ an advanced platform for genetic medicinesRead Article
Webinar – Overcoming Plasmid DNA Limitations in Advanced Therapy ManufacturingRead Article
Molecular Therapy – Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectorsRead Article
DNA Vaccines: The Next Stage in the Vaccine Revolution?Read more
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapiesRead more
22 November 2021
Touchlight Ranked Number Four Fastest Growing Technology Company in the UK in the 2021 Deloitte Technology Fast 50
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, today announced that it ranked number 4 in the 2021 Deloitte UK Technology Fast 50, a...
15 October 2021
Touchlight to break ground on world’s highest-capacity DNA manufacturing facility
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, has received the first phase of planning approval for breaking ground on its new research and...
We'd like to hear from you
For more information on how our dbDNA™ technology could help advance your project, please contact us.Get in touch